Search Results - "FLEISCHHAUER, K"

Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation by Crucitti, L, Crocchiolo, R, Toffalori, C, Mazzi, B, Greco, R, Signori, A, Sizzano, F, Chiesa, L, Zino, E, Lupo Stanghellini, M T, Assanelli, A, Carrabba, M G, Marktel, S, Marcatti, M, Bordignon, C, Corti, C, Bernardi, M, Peccatori, J, Bonini, C, Fleischhauer, K, Ciceri, F, Vago, L

“…Genomic loss of the mismatched human leukocyte antigen (HLA) is a recently described mechanism of leukemia immune escape and relapse after allogeneic…”
Get full text

Common and well‐documented HLA alleles over all of Europe and within European sub‐regions: A catalogue from the European Federation for Immunogenetics by Sanchez‐Mazas, A., Nunes, J. M., Middleton, D., Sauter, J., Buhler, S., McCabe, A., Hofmann, J., Baier, D. M., Schmidt, A. H., Nicoloso, G., Andreani, M., Grubic, Z., Tiercy, J.‐M., Fleischhauer, K.

“…Background A catalogue of common and well‐documented (CWD) human leukocyte antigen (HLA), previously established by the American Society for Histocompatibility…”
Get full text

Evidence for an association between Chlamydia psittaci and Ocular adnexal lymphomas by FERRERI, Andrés J. M, GUIDOBONI, Massimo, FRESCHI, Massimo, VILLA, Eugenio, BOIOCCHI, Mauro, DOLCETTI, Riccardo, PONZONI, Maurilio, DE CONCILIIS, Carlo, DELL'ORO, Stefania, FLEISCHHAUER, Katharina, CAGGIARI, Laura, LETTINI, Antonia A, DAL CIN, Elena, IERI, Rossella

“…Ocular adnexal lymphomas may be antigen-driven disorders; however, the source of the putative antigen or antigens is still unknown. Hence, we assessed whether…”
Get full text

Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors by Peccatori, J, Forcina, A, Clerici, D, Crocchiolo, R, Vago, L, Stanghellini, M T L, Noviello, M, Messina, C, Crotta, A, Assanelli, A, Marktel, S, Olek, S, Mastaglio, S, Giglio, F, Crucitti, L, Lorusso, A, Guggiari, E, Lunghi, F, Carrabba, M, Tassara, M, Battaglia, M, Ferraro, A, Carbone, M R, Oliveira, G, Roncarolo, M G, Rossini, S, Bernardi, M, Corti, C, Marcatti, M, Patriarca, F, Zecca, M, Locatelli, F, Bordignon, C, Fleischhauer, K, Bondanza, A, Bonini, C, Ciceri, F

“…Hematopoietic stem cell transplantation (HSCT) from human leukocyte antigen (HLA) haploidentical family donors is a promising therapeutic option for high-risk…”
Get full text

Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice by Shaw, B E, Robinson, J, Fleischhauer, K, Madrigal, J A, Marsh, S G E

Get full text

αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation by Kordelas, L, Buttkereit, U, Lindemann, M, Koldehoff, M, Klisanin, V, Horn, P A, Fleischhauer, K, Beelen, D W

Get full text

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation by Fleischhauer, K, Ahn, K W, Wang, H L, Zito, L, Crivello, P, Müller, C, Verneris, M, Shaw, B E, Pidala, J, Oudshorn, M, Lee, S J, Spellman, S R

“…In 8/8 HLA-matched unrelated donor (UD) hematopoietic cell transplants (HCT), HLA-DPB1 mismatches between alleles from different T-cell epitope (TCE) groups…”
Get full text

Jon van Rood (1926–2017) by Mueller, C, Bonini, C, Foeken, L, Chabannon, C, Bondanza, A, Fleischhauer, K, Velardi, A, Kröger, N, Kuball, J, Mohty, M

Get full text

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma by Crocchiolo, R, Ringden, O, Bay, J-O, Blaise, D, Omasic, B, Mazzi, B, Picard, C, Trinca, S, Barkholt, L, Peccatori, J, Gregori, S, Amodio, G, Fleischhauer, K, Ciceri, F, Bregni, M

“…Renal cell carcinoma (RCC) is particularly sensitive to immune intervention. HLA-G, a non-classical HLA class I molecule with immunomodulatory properties, has…”
Get full text

P1317: TIME SERIES CLUSTERING OF T CELL SUBSETS DISSECTS HETEROGENEITY IN IMMUNE RECONSTITUTION AND SURVIVAL AMONG RECIPIENTS OF MUD‐HCT WITH ATG OR PTCY by Turki, A., Leserer, S., Graf, T., Buttkereit, U., Arrieta‐Bolanos, E., Leimkühler, N., Fleischhauer, K., Beelen, D., Reinhardt, C.

Get full text

YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome by Kornblit, B, Wang, T, Lee, S J, Spellman, S R, Zhu, X, Fleischhauer, K, Müller, C, Verneris, M R, Müller, K, Johansen, J S, Vindelov, L, Garred, P

“…YKL-40, also called chitinase-3-like-1 protein, is an inflammatory biomarker that has been associated with disease severity in inflammatory and malignant…”
Get full text

The conundrum of HLA-DRB114:01 14:54 and HLA-DRB302:01 02:02 mismatches in unrelated hematopoietic SCT by Pasi, A, Crocchiolo, R, Bontempelli, M, Carcassi, C, Carella, G, Crespiatico, L, Garbarino, L, Mascaretti, L, Mazzi, B, Mazzola, G, Miotti, V, Porfirio, B, Tagliaferri, C, Valentini, T, Vecchiato, C, Fleischhauer, K, Sacchi, N, Bosi, A, Martinetti, M

“…Uncertainty still exists on the role of polymorphisms outside the HLA-DRB1 binding site or inside the HLA-DRB3 binding groove in unrelated hematopoietic SCT…”
Get full text

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1 by Fleischhauer, K, Fernandez-Viña, M A, Wang, T, Haagenson, M, Battiwalla, M, Baxter-Lowe, L A, Ciceri, F, Dehn, J, Gajewski, J, Hale, G A, Heemskerk, M B A, Marino, S R, McCarthy, P L, Miklos, D, Oudshoorn, M, Pollack, M S, Reddy, V, Senitzer, D, Shaw, B E, Waller, E K, Lee, S J, Spellman, S R

“…HLA-DP antigens are beta-alpha heterodimers encoded by polymorphic HLA-DPB1 and -DPA1 alleles, respectively, in strong linkage disequilibrium (LD) with each…”
Get full text

16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation by Petersdorf, E. W., Malkki, M., Hsu, K., Bardy, P., Cesbron, A., Dickinson, A., Dubois, V., Fleischhauer, K., Kawase, T., Madrigal, A., Morishima, Y., Shaw, B., Spellman, S., Spierings, E., Stern, M., Tiercy, J.-M., Velardi, A., Gooley, T.

“…Summary The International Histocompatibility Working Group is a collaborative international effort to understand the HLA and non‐HLA genetics of the…”
Get full text

HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry by Crocchiolo, R, Ciceri, F, Fleischhauer, K, Oneto, R, Bruno, B, Pollichieni, S, Sacchi, N, Sormani, M P, Fanin, R, Bandini, G, Bonifazi, F, Bosi, A, Rambaldi, A, Alessandrino, P E, Falda, M, Bacigalupo, A

“…The importance of HLA donor–recipient matching in unrelated haematopoietic SCT (HSCT) is the subject of debate. In this retrospective study, we analyzed 805…”
Get full text

BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT by Piras, I.S, Angius, A, Andreani, M, Testi, M, Lucarelli, G, Floris, M, Marktel, S, Ciceri, F, La Nasa, G, Fleischhauer, K, Roncarolo, M.G, Bulfone, A, Gregori, S, Bacchetta, R

Get full text

BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT by Piras, I S, Angius, A, Andreani, M, Testi, M, Lucarelli, G, Floris, M, Marktel, S, Ciceri, F, Nasa, G La, Fleischhauer, K, Roncarolo, M G, Bulfone, A, Gregori, S, Bacchetta, R

“…The genetic background of donor and recipient is an important factor determining the outcome of allogeneic hematopoietic SCT (allo-HSCT). We applied…”
Get full text

Molecular modelling of HLA-B35:132 by Longhi, E., Crivello, P., Mantovani, M., Frison, S., Fleischhauer, K., Crespiatico, L., Piccolo, G., Poli, F.

“…Summary Here we describe the molecular modelling of the new variant HLA‐B*35:132. This allele shows one mismatch with B*35:01:01:01 in exon 3 at position 575…”
Get full text

Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors by Mazzi, B, Clerici, T D, Zanussi, M, Lupo Stanghellini, M T, Vago, L, Sironi, E, Peccatori, J, Bernardi, M, Carrera, P, Palini, A, Rossini, S, Bordignon, C, Bonini, C, Ferrari, M, Ciceri, F, Fleischhauer, K

Get full text

Linking allergy to mercury to HLA and burning mouth syndrome by Pigatto, PD, Mazzi, B, Fleischhauer, K, Guzzi, G

Get full text